Curestream
Latest round
- Series A
Last raised
- May 2025
Total raised
- $7.9M
Investors
- 7
About Curestream
Curestream, founded in 2019 and headquartered in Daegu, South Korea, specializes in advanced medical solutions for diabetes management.Curestream specializes in developing advanced medical solutions for diabetes management, including a fully autonomous artificial pancreas system that uses reinforcement learning algorithms for insulin delivery. Their modular, wearable insulin pump aims to address economic challenges faced by diabetes patients.Curestream generates revenue through direct sales of its medical devices to consumers and healthcare providers, employing a direct-to-consumer business model. Customers purchase the modular insulin pump along with the intelligent insulin delivery algorithm, facilitating effective diabetes management. Future initiatives include the development of new products aimed at further improving diabetes management solutions. The company is also focused on expanding into international markets, with targeted regions and timelines to be determined as part of its strategic growth.
Who invested in Curestream
7 investors across 1 round
See all investors in Curestream
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 7, 2025
Amount
$7.9M
Investors
Questions about Curestream
Who invested in Curestream?
Curestream has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Curestream raised?
Curestream has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Curestream last raise money?
Curestream's most recent round on record is a Series A, in May 2025.
What does Curestream do?
Curestream, founded in 2019 and headquartered in Daegu, South Korea, specializes in advanced medical solutions for diabetes management.
Where is Curestream headquartered?
Curestream is headquartered in Daegu, South Korea.
Which VCs invest in companies like Curestream?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at Curestream's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Curestream? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.